Repare Therapeutics Inc.

NASDAQ: RPTX · Real-Time Price · USD
1.58
0.02 (1.28%)
At close: Aug 15, 2025, 3:59 PM
1.57
-0.63%
After-hours: Aug 15, 2025, 04:04 PM EDT

Repare Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-109.86M -127.89M -84.69M -84.05M -68.52M -45.69M -93.8M -97.42M -3.08M -29.23M -29.05M -25.68M -132.03M -120.25M -106.91M -93.88M -76.74M -62.23M
Depreciation & Amortization
3.15M 2.61M 1.92M 1.97M 1.99M 2.01M 1.95M 1.9M 1.89M 1.9M 1.98M 1.89M 1.78M 1.67M 1.47M 1.39M 1.23M 1.02M
Stock-Based Compensation
16.22M 20.67M 23.17M 24.6M 25.73M 25.48M 25.06M 23.84M 22.52M 21M 19.69M 18.45M 17.09M 15.53M 12.83M 9.94M 7.12M 4.32M
Other Working Capital
-8.57M -8.05M -18M -22.26M -37.02M -65.25M -53.81M -57.45M -15.67M 16.36M 19M 25.85M -477K 2.25M 4.64M 3.63M 2.63M 46.53M
Other Non-Cash Items
-3.22M -2.06M -2.79M 7.18M 8.45M 10.1M 9.57M -4.76M -4.76M -4.84M -3.08M 4.43M 4.43M 4.4M 4.23M 2.78M 2.41M 2.13M
Deferred Income Tax
n/a n/a n/a -10.8M -12.67M -14.76M -14.76M 3.51M 4.13M 4.93M 3.62M -4.63M -4.19M -3.35M -2.21M -2.71M -2.23M -2.39M
Change in Working Capital
-9.63M -10.83M -14.06M -16.19M -34.59M -60.57M -55.18M -55.71M -27.44M 5.64M 8.03M 15.63M 1.22M 434K 4.79M 4.48M 2.88M 46.56M
Operating Cash Flow
-103.34M -117.51M -76.44M -77.28M -79.61M -83.44M -127.16M -128.64M -7.61M -1.46M 322K 9.22M -111.71M -101.58M -85.8M -78M -65.34M -10.59M
Capital Expenditures
n/a n/a n/a -398K -398K -1.46M -1.94M 180K -86K -590K -602K -2.49M -2.54M -1.41M -1.69M -3.25M -3.4M -2.98M
Cash Acquisitions
1M n/a n/a -32.28M -32.28M -61.69M -55.48M -55.54M -55.54M -26.39M -32.6M -220K -220K 40K 40K n/a n/a n/a
Purchase of Investments
-77.6M -51.9M -133.35M -118.86M -135.44M -169.64M -179.02M -216.96M -398.37M -353.53M -256.58M -216.19M -8.04M -9.24M -7.48M -12.73M -10.96M -7.53M
Sales Maturities Of Investments
167.47M 150.47M 182.82M 169.01M 179.01M 235.51M 259M 297M 245.25M 171.25M 81.4M 8.4M 8.85M 10.1M 7.45M 5.45M 3.75M n/a
Other Investing Acitivies
n/a n/a n/a 32.28M 32.28M 61.69M 55.48M 55.54M -153.12M -182.28M -175.18M -207.47M 1.13M 1.18M 287K -7.28M -7.21M -7.53M
Investing Cash Flow
90.87M 98.58M 49.47M 49.76M 43.18M 64.41M 78.04M 80.22M -153.21M -182.87M -175.78M -210.23M -1.69M -501K -1.68M -10.53M -10.61M -10.51M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
80K 11.29B 11.29B 11.29B 11.29B n/a n/a 433K 433K 433K 646K 213K 213K 213K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a 40K 453K 618K 887K 1.05M 880K 989K 1.08M 1.33M 1.27M 1.28M 943K 249.52M
Financial Cash Flow
246K 246K 542K 646K 764K 804K 842K 902K 887K 1.05M 880K 95.28M 95.37M 95.61M 95.56M 1.28M -774K 247.8M
Net Cash Flow
-12.16M -18.76M -26.55M -26.83M -35.72M -18.24M -48.25M -47.82M -160.29M -183.68M -174.91M -105.8M -18.02M -6.48M 8.03M -87.08M -76.28M 227.71M
Free Cash Flow
-103.34M -117.51M -76.44M -77.67M -80.01M -84.9M -129.1M -128.46M -7.7M -2.05M -280K 6.73M -114.25M -102.98M -87.49M -81.25M -68.73M -13.57M